NASDAQ · EQUITY · ENHANCED MARKET DYNAMICS

SLN

Silence Therapeutics PLC

US · Healthcare · Biotechnology

Open Chart Terminal

EMD SCORE70/100

CURRENT COMPLETED-WEEK READ

Strongly constructive

The latest completed-week readings are broadly supportive. Conditions remain positive, but momentum has eased.

Constructive fade100% directional agreement100/100 evidence quality6/6 sources available

Completed week: 9 Oct 2026
Latest close: USD 9.86
Evidence: 156 weeks

Four-week EMD change-18.7 pts

signed chart scale −100 to +100

Four-week price-24.3%

completed closing prices

Current directional run26 weeks

on the same side of EMD zero

Recent consistency13/13

recent readings above zero

COMPLETED-WEEK OVERVIEW

Price and market conditions over time

3 supportive · 0 cautious

Enhanced Market Dynamics and the price cycle156 completed weeks · bars use the left EMD axis; price uses the right axis.

20 Oct 2023–9 Oct 2026

Constructive EMDCautious EMDCompleted-week priceUp-cycle confirmationDown-cycle confirmation

Confirmation markers describe price-zone departures within this saved history. Earlier markers can change as the history changes; they are not a record of signals available in real time.

Cycle position 44%Current EMD +39.14-week EMD change -18.7Full saved history price range USD 2.57–25.78

View chart values · 156 observations

Week	Close · USD	EMD −100 to +100	Score /100	Agreement %	Coverage %
2023-10-20	7.13	9.11	55	20	83
2023-10-27	7.12	13.62	57	50	83
2023-11-03	9.20	33.0	66	60	83
2023-11-10	9.20	13.39	57	33	100
2023-11-17	9.10	16.06	58	33	100
2023-11-24	11.76	64.72	82	100	100
2023-12-01	13.55	73.8	87	100	100
2023-12-08	14.50	73.5	87	100	100
2023-12-15	16.03	86.8	93	100	100
2023-12-22	16.29	73.8	87	100	100
2023-12-29	17.37	75.16	88	100	100
2024-01-05	17.92	63.35	82	67	100
2024-01-12	17.70	63.76	82	67	100
2024-01-19	18.41	83.17	92	100	100
2024-01-26	19.09	78.94	89	100	100
2024-02-02	22.28	81.69	91	100	100
2024-02-09	22.04	84.0	92	100	100
2024-02-16	22.17	77.6	89	100	100
2024-02-23	23.46	79.05	90	100	100
2024-03-01	25.78	86.76	93	100	100
2024-03-08	25.59	78.84	89	100	100
2024-03-15	22.84	60.34	80	67	100
2024-03-22	21.93	56.24	78	67	100
2024-03-29	21.60	59.98	80	100	100
2024-04-05	21.15	54.73	77	100	100
2024-04-12	22.17	58.82	79	100	100
2024-04-19	22.64	59.13	80	100	100
2024-04-26	21.60	38.34	69	33	100
2024-05-03	21.99	46.16	73	60	100
2024-05-10	21.21	30.57	65	20	100
2024-05-17	23.00	44.23	72	60	100
2024-05-24	21.91	33.44	67	33	100
2024-05-31	20.99	25.74	63	20	100
2024-06-07	20.48	23.18	62	20	100
2024-06-14	19.30	6.72	53	20	100
2024-06-21	19.65	6.98	53	0	100
2024-06-28	19.00	-10.23	45	33	100
2024-07-05	18.21	-20.52	40	60	100
2024-07-12	20.60	12.32	56	33	100
2024-07-19	20.67	6.92	53	20	100
2024-07-26	20.99	5.59	53	0	100
2024-08-02	18.85	-8.14	46	20	100
2024-08-09	16.52	-41.03	29	67	100
2024-08-16	15.69	-47.63	26	67	100
2024-08-23	16.20	-35.57	32	60	100
2024-08-30	19.09	-9.83	45	0	100
2024-09-06	18.65	-12.46	44	20	100
2024-09-13	18.69	-14.96	43	20	100
2024-09-20	18.27	-23.8	38	33	100
2024-09-27	18.25	-20.51	40	20	100
2024-10-04	18.64	-19.66	40	50	100
2024-10-11	19.65	-7.49	46	0	100
2024-10-18	17.99	-31.84	34	60	100
2024-10-25	18.08	-25.26	37	50	100
2024-11-01	17.68	-29.91	35	60	100
2024-11-08	17.52	-32.18	34	60	100
2024-11-15	12.70	-54.07	23	67	100
2024-11-22	7.01	-53.88	23	67	100
2024-11-29	7.92	-36.72	32	33	100
2024-12-06	8.52	-35.88	32	33	100
2024-12-13	6.45	-59.49	20	67	100
2024-12-20	6.88	-33.49	33	33	100
2024-12-27	7.10	-45.52	27	60	100
2025-01-03	7.39	-55.56	22	100	100
2025-01-10	5.99	-57.28	21	100	100
2025-01-17	5.12	-62.75	19	100	100
2025-01-24	5.69	-48.04	26	60	100
2025-01-31	5.33	-58.14	21	100	100
2025-02-07	5.01	-60.23	20	100	100
2025-02-14	4.84	-43.35	28	60	100
2025-02-21	4.79	-55.58	22	100	100
2025-02-28	4.50	-55.1	22	100	100
2025-03-07	4.85	-37.07	31	60	100
2025-03-14	3.91	-53.32	23	100	100
2025-03-21	3.56	-53.96	23	100	100
2025-03-28	3.44	-49.71	25	100	100
2025-04-04	2.61	-56.2	22	100	100
2025-04-11	2.57	-41.15	29	60	100
2025-04-18	3.14	-37.4	31	60	100
2025-04-25	3.36	-41.91	29	100	100
2025-05-02	3.93	-26.55	37	50	100
2025-05-09	3.70	-34.42	33	100	100
2025-05-16	4.37	-17.62	41	0	100
2025-05-23	5.06	-13.68	43	20	100
2025-05-30	5.84	0.06	50	33	100
2025-06-06	5.44	-2.78	49	0	100
2025-06-13	5.33	6.8	53	50	100
2025-06-20	5.95	17.35	59	67	100
2025-06-27	5.79	10.8	55	60	100
2025-07-04	5.52	10.63	55	60	100
2025-07-11	6.44	23.71	62	67	100
2025-07-18	6.04	12.17	56	33	100
2025-07-25	6.34	32.9	66	67	100
2025-08-01	6.17	31.65	66	60	100
2025-08-08	5.04	12.46	56	33	100
2025-08-15	5.48	20.91	60	60	100
2025-08-22	5.35	11.09	56	50	100
2025-08-29	4.81	-6.44	47	20	100
2025-09-05	5.69	19.32	60	60	100
2025-09-12	4.51	-21.04	39	60	100
2025-09-19	4.89	-4.86	48	20	100
2025-09-26	5.54	14.93	57	33	100
2025-10-03	5.00	-6.85	47	33	100
2025-10-10	5.00	-7.89	46	0	100
2025-10-17	6.50	33.16	67	67	100
2025-10-24	7.30	55.4	78	100	100
2025-10-31	7.16	46.31	73	67	100
2025-11-07	6.58	59.33	80	100	100
2025-11-14	6.83	73.76	87	100	100
2025-11-21	6.31	43.15	72	60	100
2025-11-28	6.74	63.86	82	100	100
2025-12-05	6.96	72.08	86	100	100
2025-12-12	6.32	42.54	71	67	100
2025-12-19	6.37	53.76	77	100	100
2025-12-26	6.20	38.93	69	100	100
2026-01-02	6.15	38.34	69	100	100
2026-01-09	5.52	-0.55	50	0	100
2026-01-16	5.04	-27.94	36	60	100
2026-01-23	5.67	-7.66	46	33	100
2026-01-30	4.82	-35.06	32	67	100
2026-02-06	4.75	-32.14	34	60	100
2026-02-13	4.45	-37.1	31	60	100
2026-02-20	5.00	-32.98	34	60	100
2026-02-27	5.44	-12.99	44	20	100
2026-03-06	6.23	20.82	60	67	100
2026-03-13	6.90	29.43	65	60	100
2026-03-20	6.17	17.32	59	60	100
2026-03-27	4.93	-25.64	37	33	100
2026-04-03	5.94	13.2	57	33	100
2026-04-10	5.73	-4.63	48	0	100
2026-04-17	7.53	55.95	78	100	100
2026-04-24	7.70	42.45	71	67	100
2026-05-01	7.13	41.56	71	67	100
2026-05-08	6.97	38.75	69	100	100
2026-05-15	6.10	0.8	50	0	100
2026-05-22	6.20	2.26	51	20	100
2026-05-29	6.90	29.17	65	60	100
2026-06-05	6.17	2.5	51	0	100
2026-06-12	6.69	28.22	64	60	100
2026-06-19	6.93	31.91	66	50	100
2026-06-26	10.14	81.94	91	100	100
2026-07-03	10.39	64.59	82	67	100
2026-07-10	9.09	58.72	79	67	100
2026-07-17	10.50	81.6	91	100	100
2026-07-24	11.02	75.57	88	100	100
2026-07-31	10.49	50.8	75	67	100
2026-08-07	11.95	82.23	91	100	100
2026-08-14	13.72	58.64	79	67	100
2026-08-21	13.27	62.39	81	67	100
2026-08-28	13.42	77.22	89	100	100
2026-09-04	14.59	82.03	91	100	100
2026-09-11	13.02	57.75	79	67	100
2026-09-18	12.20	53.3	77	67	100
2026-09-25	11.18	48.17	74	60	100
2026-10-02	10.64	40.4	70	60	100
2026-10-09	9.86	39.08	70	100	100

SIX SOURCES · LAST 26 OBSERVATIONS

Is support broadening or thinning?

Green is supportive, rose is cautious.
Grey means the reading is unavailable.

Reading	17 Apr	24 Apr	1 May	8 May	15 May	22 May	29 May	5 Jun	12 Jun	19 Jun	26 Jun	3 Jul	10 Jul	17 Jul	24 Jul	31 Jul	7 Aug	14 Aug	21 Aug	28 Aug	4 Sep	11 Sep	18 Sep	25 Sep	2 Oct	9 Oct
Trend	65	65	64	62	28	37	97	72	95	98	100	100	100	100	100	100	100	100	100	100	100	100	100	100	99	90
Momentum	89	90	92	93	59	57	69	45	71	84	96	96	96	96	91	81	98	98	98	99	98	73	69	55	48	52
Underlying pressure	69	83	88	90	83	71	64	54	54	55	74	89	94	97	96	96	96	97	97	97	97	95	93	85	68	48
Price & volume	82	35	40	45	41	49	53	39	59	53	87	40	17	63	50	1	63	9	21	45	60	32	24	33	34	50
Relative strength	96	95	77	46	10	11	30	14	29	34	100	100	99	100	100	100	100	100	100	100	100	100	100	99	97	87
Modeled Trend	67	72	76	80	82	83	85	86	87	88	89	89	89	89	89	90	90	91	91	91	91	90	90	90	90	90

Each cell is a finished component score from 0–100. Components can disagree even when the combined reading stays positive.

STRONGEST CURRENT SOURCE

Trend

90/100

LEAST SUPPORTIVE SOURCE

Underlying pressure

48/100

WHAT WOULD CHANGE THE READ?

Three paths to keep in view

Conditional research scenarios.
No assumed price target or timing.

Continuation

Price and evidence stay together

Look for the current direction to hold across trend, pressure and relative strength. A rising price with weaker EMD is a less convincing continuation.

Change of direction

Watch for loss of support

If price keeps rising while EMD falls, inspect which readings are weakening. Broad deterioration matters more than a single soft week.

Cycle context

A range extreme is a location

An upper zone can persist during a strong advance; a lower zone can persist during a decline. Use departures, EMD direction and the related price charts together.

EARLIER COMPARABLE READINGS

What followed similar conditions?

Same ticker · similar score and direction of change.
Returns exclude costs and dividends.

4 WEEKS LATER-3.8%

Median price return · 6 non-overlapping examples

Observed range: -24.3% to +47.0%
Positive returns: 50%
All-period comparison: -5.9% median

13 WEEKS LATER-20.8%

Median price return · 3 non-overlapping examples

Observed range: -31.8% to +94.5%
Positive returns: 33%
All-period comparison: -9.7% median

How these comparisons are selected

Earlier observations must have the same constructive/fading/repair/deterioration condition, a score within ten points of today’s score and at least the same component coverage. The first 30 observations are omitted for warm-up; examples are spaced by the forward horizon to avoid overlap. Gapped return windows are excluded. The all-period comparison uses the same available history and spacing, without matching the current state. These are reconstructed observations, not a point-in-time strategy backtest or a forecast.

RECENT CYCLE HISTORY

How the current reading developed

27 Feb 2026Up-cycle confirmedUSD 5.44

17 Oct 2025Up-cycle confirmedUSD 6.50

26 Sep 2025Up-cycle confirmedUSD 5.54

30 May 2025Up-cycle confirmedUSD 5.84

22 Nov 2024Lower cycle zone confirmedUSD 7.01

10 May 2024Down-cycle confirmedUSD 21.21

19 Apr 2024Upper cycle zone confirmedUSD 22.64

THE FULL PRICE CYCLE

Follow the journey from one zone to the other

Cycle states use trailing completed-week observations.

Lower zone

Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.

Upward journey

Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.

Upper zone

Price establishes residence near the top of its long-cycle range. A high range position can persist. Watch EMD for exhaustion and loss of support before interpreting it as a turn.

Downward journey

Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.

CURRENT READINGS